Trilostane in dogs

Ramsey, I.K. (2010) Trilostane in dogs. Veterinary Clinics of North America: Small Animal Practice, 40(2), pp. 269-283. (doi:10.1016/j.cvsm.2009.10.008)

[img] Text
30479.pdf

152kB

Abstract

Over the last 10 years, trilostane, a competitive inhibitor of steroid synthesis, is being widely used for the treatment of canine hyperadrenocorticism. Trilostane causes a significant but reversible decrease in cortisol production and a concomitant improvement in clinical signs in most dogs with this common condition. Side effects, though infrequent, can be serious: dogs treated with this drug require regular monitoring. This review summarizes current knowledge of the use of this drug with particular emphasis on its efficacy, safety, adverse reactions, and effects on endocrine parameters. Brief mention is made of its other uses in dogs and other species.

Item Type:Articles
Keywords:Hyperadrenocorticism, treatment, adrenal, steroid synthesis inhibitor
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Ramsey, Professor Ian
Authors: Ramsey, I.K.
Subjects:S Agriculture > SF Animal culture > SF600 Veterinary Medicine
College/School:College of Medical Veterinary and Life Sciences > School of Veterinary Medicine
Journal Name:Veterinary Clinics of North America: Small Animal Practice
Publisher:Elsevier
ISSN:0195-5616
ISSN (Online):1878-1306
Published Online:26 February 2010
Copyright Holders:Copyright © 2010 Elsevier
First Published:First published in Veterinary Clinics of North America: Small Animal Practice 40(2):269-283
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record